Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

18F-FDG and 68Ga-somatostatin analogs PET/CT in patients with Merkel cell carcinoma: a comparison study.

Taralli S, Sollini M, Milella M, Perotti G, Filice A, Menga M, Versari A, Rufini V.

EJNMMI Res. 2018 Jul 21;8(1):64. doi: 10.1186/s13550-018-0423-3.

2.

Distribution patterns of 18F-fluorodeoxyglucose in large vessels of Takayasu's and giant cell arteritis using positron emission tomography.

Soriano A, Pazzola G, Boiardi L, Casali M, Muratore F, Pipitone N, Catanoso M, Aldigeri R, Cimino L, Versari A, Salvarani C.

Clin Exp Rheumatol. 2018 Mar-Apr;36 Suppl 111(2):99-106. Epub 2018 May 18.

3.

Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma?

Cottereau AS, Buvat I, Kanoun S, Versari A, Casasnovas O, Chauvie S, Clerc J, Gallamini A, Meignan M.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1463-1464. doi: 10.1007/s00259-018-4005-4. Epub 2018 Apr 12. No abstract available.

PMID:
29651546
4.

Molecular Imaging of Inflammatory Arthritis and Related Disorders.

Jamar F, Versari A, Galli F, Lecouvet F, Signore A.

Semin Nucl Med. 2018 May;48(3):277-290. doi: 10.1053/j.semnuclmed.2017.12.005. Epub 2018 Jan 10. Review.

PMID:
29626944
5.

Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study.

Cottereau AS, Versari A, Luminari S, Dupuis J, Chartier L, Casasnovas RO, Berriolo-Riedinger A, Menga M, Haioun C, Tilly H, Tarantino V, Federico M, Salles G, Trotman J, Meignan M.

Blood. 2018 May 31;131(22):2449-2453. doi: 10.1182/blood-2017-11-816298. Epub 2018 Mar 20.

PMID:
29559480
6.

Effect of image registration on 3D absorbed dose calculations in 177Lu-DOTATOC peptide receptor radionuclide therapy.

Grassi E, Fioroni F, Berenato S, Patterson N, Ferri V, Braglia L, Filice A, Versari A, Iori M, Spezi E.

Phys Med. 2018 Jan;45:177-185. doi: 10.1016/j.ejmp.2017.11.021. Epub 2018 Jan 8.

PMID:
29472084
7.

Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.

Cottereau AS, Versari A, Loft A, Casasnovas O, Bellei M, Ricci R, Bardet S, Castagnoli A, Brice P, Raemaekers J, Deau B, Fortpied C, Raveloarivahy T, Van Zele E, Chartier L, Vander Borght T, Federico M, Hutchings M, Ricardi U, Andre M, Meignan M.

Blood. 2018 Mar 29;131(13):1456-1463. doi: 10.1182/blood-2017-07-795476. Epub 2018 Feb 1.

PMID:
29437590
8.

Interpretation criteria for FDG PET/CT in multiple myeloma (IMPeTUs): final results. IMPeTUs (Italian myeloma criteria for PET USe).

Nanni C, Versari A, Chauvie S, Bertone E, Bianchi A, Rensi M, Bellò M, Gallamini A, Patriarca F, Gay F, Gamberi B, Ghedini P, Cavo M, Fanti S, Zamagni E.

Eur J Nucl Med Mol Imaging. 2018 May;45(5):712-719. doi: 10.1007/s00259-017-3909-8. Epub 2017 Dec 21.

PMID:
29270787
9.

Assessment of Response to Treatment and Follow-Up in Gastroenteropancreatic Neuroendocrine Neoplasms.

Grimaldi F, Fazio N, Attanasio R, Frasoldati A, Papini E, Cremonini N, Davi MV, Funicelli L, Massironi S, Spada F, Toscano V, Versari A, Zini M, Falconi M, Oberg K.

Endocr Metab Immune Disord Drug Targets. 2017 Dec 13. doi: 10.2174/1871530318666171213145803. [Epub ahead of print]

PMID:
29237387
10.

Use of imaging techniques in large vessel vasculitis and related conditions.

Versari A, Pipitone N, Casali M, Jamar F, Pazzola G.

Q J Nucl Med Mol Imaging. 2018 Mar;62(1):34-39. doi: 10.23736/S1824-4785.17.03044-8. Epub 2017 Nov 22. Review.

11.

Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience.

Mazziotti G, Formenti AM, Panarotto MB, Arvat E, Chiti A, Cuocolo A, Dottorini ME, Durante C, Agate L, Filetti S, Felicetti F, Filice A, Pace L, Pellegrino T, Rodari M, Salvatori M, Tranfaglia C, Versari A, Viola D, Frara S, Berruti A, Giustina A, Giubbini R.

Endocrine. 2018 Jan;59(1):90-101. doi: 10.1007/s12020-017-1455-6. Epub 2017 Nov 6.

PMID:
29110129
12.

Labelling of 90Y- and 177Lu-DOTA-Bioconjugates for Targeted Radionuclide Therapy: A Comparison among Manual, Semiautomated, and Fully Automated Synthesis.

Iori M, Capponi PC, Rubagotti S, Esposizione LR, Seemann J, Pitzschler R, Dreger T, Formisano D, Grassi E, Fioroni F, Versari A, Asti M.

Contrast Media Mol Imaging. 2017 May 25;2017:8160134. doi: 10.1155/2017/8160134. eCollection 2017.

13.

Usefulness of PET in recognizing and managing vasculitides.

Pipitone NAM, Versari A, Salvarani C.

Curr Opin Rheumatol. 2018 Jan;30(1):24-29. doi: 10.1097/BOR.0000000000000459. Review.

PMID:
29035930
14.

Added diagnostic value of respiratory-gated 4D 18F-FDG PET/CT in the detection of liver lesions: a multicenter study.

Crivellaro C, De Ponti E, Elisei F, Morzenti S, Picchio M, Bettinardi V, Versari A, Fioroni F, Dziuk M, Tkaczewski K, Ahond-Vionnet R, Nodari G, Todde S, Landoni C, Guerra L.

Eur J Nucl Med Mol Imaging. 2018 Jan;45(1):102-109. doi: 10.1007/s00259-017-3795-0. Epub 2017 Aug 19.

PMID:
28825125
15.

Peptide Receptor Radionuclide Therapy-Induced Gitelman-like Syndrome.

Negro A, Rossi GM, Nicoli D, Versari A, Farnetti E, Santi R, De Pietri S.

Am J Kidney Dis. 2017 Nov;70(5):725-728. doi: 10.1053/j.ajkd.2017.05.024. Epub 2017 Jul 21.

PMID:
28739329
16.

Severe Rhabdomyolysis during Treatment with Trabectedin in Combination with a Herbal Drug in a Patient with Metastatic Synovial Sarcoma: A Case Report.

Damato A, Larocca M, Rondini E, Menga M, Pinto C, Versari A.

Case Rep Oncol. 2017 Mar 28;10(1):258-264. doi: 10.1159/000464440. eCollection 2017 Jan-Apr. Erratum in: Case Rep Oncol. 2017 May 23;10 (2):455.

17.

Uptake of Ga-curcumin derivatives in different cancer cell lines: Toward the development of new potential 68Ga-labelled curcuminoids-based radiotracers for tumour imaging.

Rubagotti S, Croci S, Ferrari E, Orteca G, Iori M, Capponi PC, Versari A, Asti M.

J Inorg Biochem. 2017 Aug;173:113-119. doi: 10.1016/j.jinorgbio.2017.05.002. Epub 2017 May 10.

PMID:
28511061
18.

Interleukin-6 and soluble interleukin-6 receptor are elevated in large-vessel vasculitis: a cross-sectional and longitudinal study.

Pulsatelli L, Boiardi L, Assirelli E, Pazzola G, Muratore F, Addimanda O, Dolzani P, Versari A, Casali M, Magnani L, Pignotti E, Pipitone N, Croci S, Meliconi R, Salvarani C.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):102-110. Epub 2017 Apr 20.

PMID:
28466804
19.

Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

André MPE, Girinsky T, Federico M, Reman O, Fortpied C, Gotti M, Casasnovas O, Brice P, van der Maazen R, Re A, Edeline V, Fermé C, van Imhoff G, Merli F, Bouabdallah R, Sebban C, Specht L, Stamatoullas A, Delarue R, Fiaccadori V, Bellei M, Raveloarivahy T, Versari A, Hutchings M, Meignan M, Raemaekers J.

J Clin Oncol. 2017 Jun 1;35(16):1786-1794. doi: 10.1200/JCO.2016.68.6394. Epub 2017 Mar 14.

PMID:
28291393
20.

Report of the 6th International Workshop on PET in lymphoma.

Nanni C, Cottereau AS, Lopci E, Bodet-Milin C, Coronado M, Pro B, Kim WS, Trotman J, Barrington S, Duhrsen U, Vander Borght T, Zamagni E, Kraeber-Bodéré F, Messiou C, Rahmouni A, Buvat I, Andre M, Hertzberg M, Oyen W, Casasnovas O, Luminari S, Garderet L, Montravers F, Kobe C, Kluge R, Versari A, Zucca E, Moreau P, Cheson B, Haioun C, Gallamini A, Meignan M.

Leuk Lymphoma. 2017 Oct;58(10):2298-2303. doi: 10.1080/10428194.2017.1298752. Epub 2017 Mar 7.

PMID:
28264597
21.

Reply to H.J.A. Adams et al and E. Laffon et al.

Meignan M, Cottereau AS, Versari A, Chartier L, Dupuis J, Boussetta S, Grassi I, Casasnovas RO, Haioun C, Tilly H, Tarantino V, Dubreuil J, Federico M, Salles G, Luminari S, Trotman J.

J Clin Oncol. 2017 Mar 10;35(8):920-923. doi: 10.1200/JCO.2016.71.0459. Epub 2016 Dec 28. No abstract available.

PMID:
28029310
22.

Out-group threats and distress as antecedents of common in-group identity among majority and minority group members in the aftermath of a natural disaster.

Vezzali L, Versari A, Cadamuro A, Trifiletti E, Di Bernardo GA.

Int J Psychol. 2016 Dec 19. doi: 10.1002/ijop.12406. [Epub ahead of print]

PMID:
27990634
23.

Do we need FDG-PET/CT to assess atherosclerosis?

Pipitone N, Salvarani C, Versari A.

Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):247-248. doi: 10.1007/s00259-016-3568-1. No abstract available.

PMID:
27864590
24.

Extra-articular rheumatoid arthritis imaged by [18F]FDG-PET/CT.

Sollini M, Muratore F, Roncali M, Erba PA, Salvarani C, Versari A.

Acta Reumatol Port. 2016 Jul-Sep;41(3):268. No abstract available.

PMID:
27771731
25.

Antioxidant activity of commercial food grade tannins exemplified in a wine model.

Ricci A, Olejar KJ, Parpinello GP, Mattioli AU, Teslić N, Kilmartin PA, Versari A.

Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2016 Dec;33(12):1761-1774. Epub 2016 Oct 24.

PMID:
27696959
26.

Extra-articular rheumatoid arthritis imaged by [18F]FDG-PET/CT.

Sollini M, Muratore F, Roncali M, Erba PA, Salvarani C, Versari A.

Acta Reumatol Port. 2016 Mar 25. [Epub ahead of print] No abstract available.

PMID:
27682580
27.

Affinity of (nat/68)Ga-Labelled Curcumin and Curcuminoid Complexes for β-Amyloid Plaques: Towards the Development of New Metal-Curcumin Based Radiotracers.

Rubagotti S, Croci S, Ferrari E, Iori M, Capponi PC, Lorenzini L, Calzà L, Versari A, Asti M.

Int J Mol Sci. 2016 Sep 6;17(9). pii: E1480. doi: 10.3390/ijms17091480.

28.

Detection of a second malignancy in prostate cancer patients by using [(18)F]Choline PET/CT: a case series.

Sollini M, Pasqualetti F, Perri M, Coraggio G, Castellucci P, Roncali M, Boni R, Lazzeri E, Galeandro M, Paiar F, Versari A, Erba PA.

Cancer Imaging. 2016 Aug 31;16(1):27. doi: 10.1186/s40644-016-0085-1.

29.

Baseline Metabolic Tumor Volume Predicts Outcome in High-Tumor-Burden Follicular Lymphoma: A Pooled Analysis of Three Multicenter Studies.

Meignan M, Cottereau AS, Versari A, Chartier L, Dupuis J, Boussetta S, Grassi I, Casasnovas RO, Haioun C, Tilly H, Tarantino V, Dubreuil J, Federico M, Salles G, Luminari S, Trotman J.

J Clin Oncol. 2016 Aug 22. pii: JCO669440. [Epub ahead of print]

PMID:
27551111
30.

Training improves the interobserver agreement of the expert positron emission tomography review panel in primary mediastinal B-cell lymphoma: interim analysis in the ongoing International Extranodal Lymphoma Study Group-37 study.

Ceriani L, Barrington S, Biggi A, Malkowski B, Metser U, Versari A, Martelli M, Davies A, Johnson PW, Zucca E, Chauvie S.

Hematol Oncol. 2017 Dec;35(4):548-553. doi: 10.1002/hon.2339. Epub 2016 Aug 22. Review.

PMID:
27545416
31.

Extraction and evaluation of natural occurring bioactive compounds and change in antioxidant activity during red winemaking.

Ivanova-Petropulos V, Durakova S, Ricci A, Parpinello GP, Versari A.

J Food Sci Technol. 2016 Jun;53(6):2634-43. doi: 10.1007/s13197-016-2235-7. Epub 2016 Jun 1.

32.

Skin dose saving of the staff in 90Y/177Lu peptide receptor radionuclide therapy with the automatic dose dispenser.

Fioroni F, Grassi E, Giorgia C, Sara R, Piccagli V, Filice A, Mostacci D, Versari A, Iori M.

Nucl Med Commun. 2016 Oct;37(10):1046-52. doi: 10.1097/MNM.0000000000000548.

PMID:
27218429
33.

The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma).

Chauvie S, Bergesio F, Fioroni F, Brambilla M, Biggi A, Versari A, Guerra L, Storto G, Musto P, Luminari S, Cabras MG, Balzarotti M, Rigacci L, Martelli M, Vitolo U, Federico M, Gallamini A.

Phys Med. 2016 May;32(5):651-6. doi: 10.1016/j.ejmp.2016.04.004. Epub 2016 Apr 28.

PMID:
27133138
34.

Contrast-Enhanced Ultrasound of the Carotid Artery in Patients With Large Vessel Vasculitis: Correlation With Positron Emission Tomography Findings.

Germanò G, Macchioni P, Possemato N, Boiardi L, Nicolini A, Casali M, Versari A, Pipitone N, Salvarani C.

Arthritis Care Res (Hoboken). 2017 Jan;69(1):143-149. doi: 10.1002/acr.22906. Epub 2016 Nov 16.

35.

Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients.

Ciammella P, Filippi AR, Simontacchi G, Buglione M, Botto B, Mangoni M, Iotti C, Merli F, Marcheselli L, Bisi G, Ricardi U, Versari A.

Br J Radiol. 2016;89(1061):20150983. doi: 10.1259/bjr.20150983. Epub 2016 Mar 24.

36.

Spectroscopy analysis of phenolic and sugar patterns in a food grade chestnut tannin.

Ricci A, Lagel MC, Parpinello GP, Pizzi A, Kilmartin PA, Versari A.

Food Chem. 2016 Jul 15;203:425-429. doi: 10.1016/j.foodchem.2016.02.105. Epub 2016 Feb 16.

PMID:
26948634
37.

Attenuated Total Reflection Mid-Infrared (ATR-MIR) Spectroscopy and Chemometrics for the Identification and Classification of Commercial Tannins.

Ricci A, Parpinello GP, Olejar KJ, Kilmartin PA, Versari A.

Appl Spectrosc. 2015 Nov;69(11):1243-50. doi: 10.1366/15-07957.

PMID:
26647047
38.

Post-Synthesis Incorporation of ⁶⁴Cu in CuS Nanocrystals to Radiolabel Photothermal Probes: A Feasible Approach for Clinics.

Riedinger A, Avellini T, Curcio A, Asti M, Xie Y, Tu R, Marras S, Lorenzoni A, Rubagotti S, Iori M, Capponi PC, Versari A, Manna L, Seregni E, Pellegrino T.

J Am Chem Soc. 2015 Dec 9;137(48):15145-51. doi: 10.1021/jacs.5b07973. Epub 2015 Nov 25.

PMID:
26551614
39.

18F-FDG PET/CT focal, but not osteolytic, lesions predict the progression of smoldering myeloma to active disease.

Zamagni E, Nanni C, Gay F, Pezzi A, Patriarca F, Bellò M, Rambaldi I, Tacchetti P, Hillengass J, Gamberi B, Pantani L, Magarotto V, Versari A, Offidani M, Zannetti B, Carobolante F, Balma M, Musto P, Rensi M, Mancuso K, Dimitrakopoulou-Strauss A, Chauviè S, Rocchi S, Fard N, Marzocchi G, Storto G, Ghedini P, Palumbo A, Fanti S, Cavo M.

Leukemia. 2016 Feb;30(2):417-22. doi: 10.1038/leu.2015.291. Epub 2015 Oct 22.

PMID:
26490489
40.

Image interpretation criteria for FDG PET/CT in multiple myeloma: a new proposal from an Italian expert panel. IMPeTUs (Italian Myeloma criteria for PET USe).

Nanni C, Zamagni E, Versari A, Chauvie S, Bianchi A, Rensi M, Bellò M, Rambaldi I, Gallamini A, Patriarca F, Gay F, Gamberi B, Cavo M, Fanti S.

Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):414-21. doi: 10.1007/s00259-015-3200-9. Epub 2015 Oct 16.

PMID:
26475305
41.

Positron emission tomography response and minimal residual disease impact on progression-free survival in patients with follicular lymphoma. A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi.

Luminari S, Galimberti S, Versari A, Biasoli I, Anastasia A, Rusconi C, Ferrari A, Petrini M, Manni M, Federico M.

Haematologica. 2016 Feb;101(2):e66-8. doi: 10.3324/haematol.2015.132811. Epub 2015 Oct 15. No abstract available.

42.

Somatostatin receptor positron emission tomography/computed tomography imaging in Merkel cell carcinoma.

Sollini M, Taralli S, Milella M, Erba PA, Rubagotti S, Fraternali A, Roncali M, Moscarella E, Perotti G, Rufini V, Versari A.

J Eur Acad Dermatol Venereol. 2016 Sep;30(9):1507-11. doi: 10.1111/jdv.13405. Epub 2015 Oct 7.

PMID:
26446694
43.

Time Evolution of DOTATOC Uptake in Neuroendocrine Tumors in View of a Possible Application of Radioguided Surgery with β- Decay.

Collamati F, Bellini F, Bocci V, De Lucia E, Ferri V, Fioroni F, Grassi E, Iori M, Marafini M, Morganti S, Paramatti R, Patera V, Recchia L, Russomando A, Sarti A, Sciubba A, Senzacqua M, Solfaroli Camillocci E, Versari A, Voena C, Faccini R.

J Nucl Med. 2015 Oct;56(10):1501-6. doi: 10.2967/jnumed.115.160481. Epub 2015 Sep 3.

44.

Diagnostic performances of [18F]fluorocholine positron emission tomography in brain tumors.

Sollini M, Sghedoni R, Erba PA, Cavuto S, Froio A, De Berti G, Pisanello A, Fraternali A, Iori M, Iaccarino C, Iori M, Asti M, Filice A, Versari A.

Q J Nucl Med Mol Imaging. 2018 Jun;62(2):209-219. doi: 10.23736/S1824-4785.17.02807-2. Epub 2015 Sep 1.

PMID:
26329494
45.

Chronic periaortitis with thoracic aorta and epiaortic artery involvement: a systemic large vessel vasculitis?

Palmisano A, Urban ML, Corradi D, Cobelli R, Alberici F, Maritati F, Versari A, Pipitone N, Salvarani C, Buzio C, Vaglio A.

Rheumatology (Oxford). 2015 Nov;54(11):2004-9. doi: 10.1093/rheumatology/kev225. Epub 2015 Jun 23.

PMID:
26106209
46.

Adding variables to complexity. Molecular imaging and molecular biology: a no-longer-secret liaison in NETs.

Versari A, Ciarrocchi A.

Eur J Nucl Med Mol Imaging. 2015 Aug;42(9):1339-40. doi: 10.1007/s00259-015-3097-3. No abstract available.

PMID:
26067089
47.

Development of a simple kit-based method for preparation of pharmaceutical-grade ⁶⁸Ga-DOTATOC.

Asti M, Iori M, Capponi PC, Rubagotti S, Fraternali A, Versari A.

Nucl Med Commun. 2015 May;36(5):502-10. doi: 10.1097/MNM.0000000000000275.

PMID:
25695611
48.

Applications of PET imaging with radiolabelled choline (11C/18F-choline).

Kirienko M, Sollini M, Lopci E, Versari A, Chiti A.

Q J Nucl Med Mol Imaging. 2015 Mar;59(1):83-94. Epub 2015 Feb 12. Review.

PMID:
25677590
49.

Multicenter comparison of 18F-FDG and 68Ga-DOTA-peptide PET/CT for pulmonary carcinoid.

Lococo F, Perotti G, Cardillo G, De Waure C, Filice A, Graziano P, Rossi G, Sgarbi G, Stefanelli A, Giordano A, Granone P, Rindi G, Versari A, Rufini V.

Clin Nucl Med. 2015 Mar;40(3):e183-9. doi: 10.1097/RLU.0000000000000641.

PMID:
25608152
50.

Monitoring peroxides generation during model wine fermentation by FOX-1 assay.

Bridi R, González A, Bordeu E, López-Alarcón C, Aspée A, Diethelm B, Lissi E, Parpinello GP, Versari A.

Food Chem. 2015 May 15;175:25-8. doi: 10.1016/j.foodchem.2014.11.126. Epub 2014 Nov 28.

PMID:
25577046

Supplemental Content

Loading ...
Support Center